Pfizer exits ViiV Healthcare in $1.9B deal, Shionogi doubles stake to 21.7%, while GSK retains majority, advancing long-acting HIV treatments and prevention.
GSK has agreed to acquire RAPT Therapeutics for $2.2 billion, adding ozureprubart, a long-acting anti-IgE antibody, to its pipeline and strengthening its push into food allergy treatment.
Syngene International has extended its strategic research collaboration with Bristol Myers Squibb through 2035, expanding integrated services across discovery, development, manufacturing, and clinical programs.
Manthan 2026, a Research & Development Leadership Symposium, concluded successfully at Novotel, Mumbai. The insightful day-long symposium brought together eminent voices, leaders, and experts from across India’s life sciences and clinical...
Granules India is actively exploring acquisitions in the injectables segment, with deal sizes capped at $50 million, as it targets quality-led growth amid global shortages and rising demand for complex formulations.
AbbVie today reported positive topline results from its Phase 3 EPCORE DLBCL-1 trial, showing epcoritamab improved progression-free survival in adults with relapsed or refractory diffuse large B-cell lymphoma.
Novo Nordisk’s Wegovy pill is seeing encouraging early demand in the U.S., giving the drugmaker a head start in the fast-growing weight-loss market as it competes with Eli Lilly’s upcoming oral treatment.
Novartis announced today that the FDA has granted Breakthrough Therapy designation to ianalumab for Sjogren’s disease, strengthening its path toward becoming the first targeted treatment for this autoimmune condition.
Sun Pharmaceutical Industries has launched Unloxcyt in the United States following FDA approval of an updated label, expanding treatment options for patients with advanced cutaneous squamous cell carcinoma.
Boston Scientific Corporation has signed a definitive agreement to acquire US-based medical device company Penumbra Inc. in a transaction valued at approximately $14.5 billion, strengthening its presence in vascular and neurovascular therapi...
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")